Jacob Anglister
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Virology top 1%
- Immunology top 5%
- Spectroscopy top 2%
- Co-authors
- Stephan GrzesiekAd BaxIzchak Z. SteinbergTali ScherfFred NaiderRina LevyMichal SharonHao Ren
- Topics
- Monoclonal and Polyclonal Antibodies Research (43 papers)HIV Research and Treatment (30 papers)Glycosylation and Glycoproteins Research (21 papers)
- Journals
- NatureProceedings of the National Academy of SciencesJournal of the American Chemical Society
- Partner nations
- IsraelUnited StatesFrance
In The Last Decade
Jacob Anglister
89 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 2.4k
- Radiology, Nuclear Medicine and Imaging 766
- Virology 615
- Immunology 500
- Spectroscopy 472
Countries citing papers authored by Jacob Anglister
This map shows the geographic impact of Jacob Anglister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Anglister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Anglister more than expected).
Fields of papers citing papers by Jacob Anglister
This network shows the impact of papers produced by Jacob Anglister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Anglister. The network helps show where Jacob Anglister may publish in the future.
Co-authorship network of co-authors of Jacob Anglister
This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Anglister. A scholar is included among the top collaborators of Jacob Anglister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Anglister. Jacob Anglister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 7 | |
| 3 | 6 | |
| 4 | 2 | |
| 5 | 28 | |
| 6 | 18 | |
| 7 | 5 | |
| 8 | 40 | |
| 9 | 68 | |
| 10 | 86 | |
| 11 | 53 | |
| 12 | 49 | |
| 13 | 10 | |
| 14 | 7 | |
| 15 | 87 | |
| 16 | 41 | |
| 17 | 36 | |
| 18 | 32 | |
| 19 | 49 | |
| 20 | 32 |
About Jacob Anglister
Jacob Anglister is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Biophysics, having authored 89 papers that have together received 3.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (43 papers), HIV Research and Treatment (30 papers) and Glycosylation and Glycoproteins Research (21 papers). The work is most often cited by research in Virology (615 citations), Molecular Biology (2.4k citations) and Radiology, Nuclear Medicine and Imaging (766 citations). Jacob Anglister has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Stephan Grzesiek, Ad Bax, Izchak Z. Steinberg, Tali Scherf, Fred Naider, Rina Levy, Michal Sharon, Hao Ren, Jordan H. Chill and Naama Kessler. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.